BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28202545)

  • 1. The Basis for Acyl Specificity in the Tafazzin Reaction.
    Schlame M; Xu Y; Ren M
    J Biol Chem; 2017 Mar; 292(13):5499-5506. PubMed ID: 28202545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species.
    Malhotra A; Xu Y; Ren M; Schlame M
    Biochim Biophys Acta; 2009 Apr; 1791(4):314-20. PubMed ID: 19416660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzymatic function of tafazzin.
    Xu Y; Malhotra A; Ren M; Schlame M
    J Biol Chem; 2006 Dec; 281(51):39217-24. PubMed ID: 17082194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Acyl Chain Composition of Phosphatidylcholine in Tafazzin-Mediated Remodeling of Cardiolipin in Liposomes.
    Abe M; Sawada Y; Uno S; Chigasaki S; Oku M; Sakai Y; Miyoshi H
    Biochemistry; 2017 Nov; 56(47):6268-6280. PubMed ID: 29091407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of molecular species of mitochondrial cardiolipin 2. A mathematical model of pattern formation by phospholipid transacylation.
    Schlame M
    Biochim Biophys Acta; 2009 Apr; 1791(4):321-5. PubMed ID: 19416646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.
    Abe M; Hasegawa Y; Oku M; Sawada Y; Tanaka E; Sakai Y; Miyoshi H
    J Biol Chem; 2016 Jul; 291(30):15491-502. PubMed ID: 27268057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physical state of lipid substrates provides transacylation specificity for tafazzin.
    Schlame M; Acehan D; Berno B; Xu Y; Valvo S; Ren M; Stokes DL; Epand RM
    Nat Chem Biol; 2012 Oct; 8(10):862-9. PubMed ID: 22941046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of cardiolipin by phospholipid transacylation.
    Xu Y; Kelley RI; Blanck TJ; Schlame M
    J Biol Chem; 2003 Dec; 278(51):51380-5. PubMed ID: 14551214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylation of monolysocardiolipin in rat heart.
    Ma BJ; Taylor WA; Dolinsky VW; Hatch GM
    J Lipid Res; 1999 Oct; 40(10):1837-45. PubMed ID: 10508203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells.
    Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA
    J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.
    Schlame M; Xu Y
    J Mol Biol; 2020 Aug; 432(18):5043-5051. PubMed ID: 32234310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Drosophila model of Barth syndrome.
    Xu Y; Condell M; Plesken H; Edelman-Novemsky I; Ma J; Ren M; Schlame M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11584-8. PubMed ID: 16855048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Arabidopsis thaliana lysophospholipid acyltransferase At1g78690p acylates lysocardiolipins.
    Moncada RM; Blackshear KJ; Garrett TA
    Biochem Biophys Res Commun; 2017 Nov; 493(1):340-345. PubMed ID: 28888983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigmatic role of tafazzin in cardiolipin metabolism.
    Houtkooper RH; Turkenburg M; Poll-The BT; Karall D; Pérez-Cerdá C; Morrone A; Malvagia S; Wanders RJ; Kulik W; Vaz FM
    Biochim Biophys Acta; 2009 Oct; 1788(10):2003-14. PubMed ID: 19619503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
    Mejia EM; Cole LK; Hatch GM
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.
    Kimura T; Kimura AK; Ren M; Berno B; Xu Y; Schlame M; Epand RM
    Biochemistry; 2018 Apr; 57(14):2162-2175. PubMed ID: 29557170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling.
    Baile MG; Whited K; Claypool SM
    Mol Biol Cell; 2013 Jun; 24(12):2008-20. PubMed ID: 23637464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome.
    Malhotra A; Edelman-Novemsky I; Xu Y; Plesken H; Ma J; Schlame M; Ren M
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2337-41. PubMed ID: 19164547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.